With obesity, there are just so many patients, says Krista Mistovich, Pharm.D., a pharmacist who works in managed care
How to Interpret the Evidence Clinically Even with consistent observational associations, several points remain critical: Confounding remains likely
Even more concerning, some individuals experience: Gallbladder issues Pancreatitis Malnutrition from chronic nausea and reduced food intake Rebound weight gain if the medication is stopped And perhaps most problematic: semaglutide doesnt teach your body how to metabolize properlyit just suppresses hunger signals
You are not broken
When starting a GLP-1 medication like Ozempic or Wegovy, its normal to experience side effects such as mild nausea, reduced appetite, or changes in digestion
Factors such as a high prevalence of diabetes, increasing obesity rates, and a well-established healthcare infrastructure drive the demand for advanced diabetes treatments in this region